Patents by Inventor Paraskevi Heldin

Paraskevi Heldin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11730811
    Abstract: The present invention discloses a method for treating a subject suffering from a Flavivirus infection. The method includes a step of administering to the subject a pharmaceutical composition including a pharmaceutically effective amount of an anti-CD44 antibody.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: August 22, 2023
    Assignee: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Yen-Hsu Chen, Chun-Yu Lin, Paraskevi Heldin
  • Publication number: 20210205450
    Abstract: The present invention discloses a method for treating a subject suffering from a Flavivirus infection. The method includes a step of administering to the subject a pharmaceutical composition including a pharmaceutically effective amount of an anti-CD44 antibody.
    Type: Application
    Filed: March 17, 2021
    Publication date: July 8, 2021
    Applicant: Kaohsiung Medical University
    Inventors: Yen-Hsu Chen, Chun-Yu Lin, Paraskevi Heldin
  • Publication number: 20190107538
    Abstract: The present invention discloses a method to determine whether a warning sign will occur in a subject with the Flavivirus infectious illness, and a pharmaceutical composition. The method includes steps of measuring the level of serum hyaluronan of the subject, and determining that the warning sign will occur in his/her illness course when the level is higher than or equal to 70 ng/mL. It is identified in the invention that the level of the serum hyaluronan is an excellent predicator for the severity of the Flavivirus infectious illness.
    Type: Application
    Filed: January 26, 2018
    Publication date: April 11, 2019
    Applicant: Kaohsiung Medical University
    Inventors: Yen-Hsu Chen, Chun-Yu Lin, Paraskevi Heldin